Science Talk

When Alfred Samuels was diagnosed with advanced prostate cancer in 2012, it felt as if his world had fallen apart overnight. Doctors said surgery wasn’t an option for him because the cancer had spread beyond his prostate, and he started to lose hope. But then he joined a clinical trial and began treatment with abiraterone, a drug discovered and developed by our scientists, which is now extending the lives of thousands of men worldwide. Eleven years later, Alfred explains how he wouldn’t be here today without our research.

Sue’s husband, Philip, was entered onto a clinical trial for abiraterone when his prostate cancer developed resistance to the treatment he was on. She tells us what a difference it made to their lives.

Professor Nick James, Chief Investigator of the STAMPEDE trial, joined the ICR in December 2019 and is one of our newest Team Leaders. Diana Cano Bordajandi met him to find out more about his current research and future plans, which will help us answer key questions on how to treat men with prostate cancer.